Open AccessPB2065: IMPORTANCE OF PET AS A PROGNOSTIC MARKER IN TREATMENT STRATEGY CHOICE IN PATIENTS WITH HODGKIN LYMPHOMA
Author(s) -
Novosad O.,
Pastushenko I.,
Kadnikova T.,
Tytorenko I.,
Martynchyk A.,
Gorbach O.,
Ashyhmin A.,
Kmetyuk Y.,
Karpova O.,
Mykhalska L.,
Kindrakevych O.,
Novikov M.,
Oliinichenko O.,
Kriachok I.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851092.94445.bd
Subject(s) - abvd , medicine , nuclear medicine , stage (stratigraphy) , clinical endpoint , positron emission tomography , regimen , oncology , clinical trial , radiology , chemotherapy , paleontology , vincristine , biology , cyclophosphamide